ADVERTISEMENT

404

Not Found

Is this what you were looking for?

tag induced pluripotent stem cells developmental biology immunology

A person moving the hands of a vintage clock backwards.
Synthetic Circuits Reveal the Key to Rewinding the Cellular Clock
Charlene Lancaster, PhD | Mar 12, 2024 | 4 min read
Using a circuit-based system, scientists determined the ideal transcription factor levels to promote the successful reprogramming of fibroblasts into induced pluripotent stem cells.
Stem Cell Trial for Eye Disease Commences
Jef Akst | Sep 12, 2014 | 2 min read
Researchers at the RIKEN Center for Developmental Biology will treat the first patient in its clinical trial testing an induced pluripotent stem cell-based treatment for age-related macular degeneration.
Synthego Launches High Throughput Induced Pluripotent Stem Cell Genome Engineering
Synthego | Oct 29, 2019 | 2 min read
National Institutes of Health awards contract for CRISPR-based disease modeling in iPS cell lines associated with Alzheimer’s, Stem cell pioneer Bill Skarnes joins advisory board
Use of Induced Pluripotent Stem Cells in Drug Discovery: Challenges and Opportunities
The Scientist Marketing Team | Sep 26, 2013 | 3 min read
The Scientist brings together a panel of experts who parse the hope and hype in an effort to educate the audience about the successes and caveats of using iPSCs.
A bat flying in a dark cave
Turning on the Bat Signal
Hannah Thomasy, PhD | Mar 15, 2024 | 10+ min read
Scientists around the world investigate how bat immune systems cope with viral attacks and how this information could be used to keep humans safe.
Stem Cells Made Waves in Biology and Medicine
Karen Zusi | Oct 1, 2016 | 6 min read
Since their introduction to the lab, pluripotent stem cells have gone from research tool to therapeutic, but the journey has been rocky.
Stem Cell Trial Nearly Approved
Jef Akst | Feb 15, 2013 | 1 min read
The first human trial of a treatment using induced pluripotent stem cells has received conditional approval from an institutional review board in Japan.
Regulators OK Clinical Trials Using Donor Stem Cells
Kerry Grens | Feb 5, 2017 | 2 min read
Japanese health officials approve human experiments to treat macular degeneration with a cell therapy derived from induced pluripotent stem cells.
Rebooting pluripotency
Cathy Holding(cholding@hgmp.mrc.ac.uk) | Jul 15, 2003 | 2 min read
expression could reprogram adult cells to a stem cell condition
Pluripotency: the third option?
Elie Dolgin | Jun 15, 2009 | 4 min read
The excitement surrounding cellular reprogramming and the possibility of federal funding for human embryonic stem cell (ESC) research in the US could be overshadowing another promising therapeutic source of stem cells: those derived via parthenogenesis, some researchers say. But later-developed techniques such as induced pluripotent stem cells (iPSCs) could make this approach obsolete, and the final draft of the stem cell guidelines, due out by July 7, might put the nail in the parthenote coffin

Run a Search

ADVERTISEMENT